人骨髓間充質(zhì)干細(xì)胞 HMSC-bm
如果您對該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: 人骨髓間充質(zhì)干細(xì)胞 HMSC-bm
產(chǎn)品型號: HMSC-bm；
產(chǎn)品展商: ScienCell
產(chǎn)品文檔: 無相關(guān)文檔
簡單介紹
人骨髓間充質(zhì)干細(xì)胞 HMSC-bm 人骨髓間充質(zhì)干細(xì)胞 HMSC-bm 上海 安徽 合肥 ScienCell細(xì)胞庫?
人骨髓間充質(zhì)干細(xì)胞 HMSC-bm
的詳細(xì)介紹
間充質(zhì)干細(xì)胞是特征明確的一類**干細(xì)胞。它們有發(fā)育為成熟細(xì)胞的潛在能力而產(chǎn)生脂肪、軟骨、骨骼和肌肉。這些特性與它們發(fā)育中的可塑性共同作用，使人們對用間充質(zhì)干細(xì)胞來替換受損組織的潛在能力產(chǎn)生了極大的興趣。間充質(zhì)干細(xì)胞無血清培養(yǎng)，在轉(zhuǎn)化生長因子作用下會分化成軟骨細(xì)胞。相反，在有血清、抗壞血酸和地塞米松的作用下會分化成成骨細(xì)胞。間充質(zhì)干細(xì)胞有能力更新和分化成多種間充質(zhì)組織。間充質(zhì)干細(xì)胞有潛能被移植到受損傷的部位或者種植到仿生支架上，生長形成適當(dāng)?shù)慕M織結(jié)構(gòu)。
Sciencell研究實驗室的人骨髓間充質(zhì)干細(xì)胞是從人骨髓組織中分離得到的，原代凍存，冰凍運輸。每管細(xì)胞密度超過5×10^5/ml。人骨髓間充質(zhì)干細(xì)胞經(jīng)免疫熒光鑒定、和CD73，CD90，CD105的抗體鑒定，以及分化后的脂質(zhì)染色鑒定。本細(xì)胞經(jīng)檢測不含HIV-1、HBV、HCV、支原體、細(xì)菌、酵母菌和真菌。如采用ScienCell 實驗室特制的培養(yǎng)基，可保證此細(xì)胞15倍增。
推薦培養(yǎng)基：間充質(zhì)干細(xì)胞培養(yǎng)基?(MSCM, Cat. #7501)
|
貨號
|
7500
|
|
產(chǎn)地
|
美國
|
|
縮寫
|
HMSC-ad
|
|
規(guī)格
|
5 x 10^5 /1ml
|
|
用途
|
科研
|
|
儲存
|
液氮
|
|
運輸
|
干冰
|
|
關(guān)鍵字
|
人骨髓間充質(zhì)干細(xì)胞 HMSC-bm 人骨髓間充質(zhì)干細(xì)胞 HMSC-bm 人骨髓間充質(zhì)干細(xì)胞 HMSC-bm 人骨髓間充質(zhì)干細(xì)胞 HMSC-bm 人骨髓間充質(zhì)干細(xì)胞 HMSC-bm 人骨髓間充質(zhì)干細(xì)胞 HMSC-bm 人骨髓間充質(zhì)干細(xì)胞 HMSC-bm 人骨髓間充質(zhì)干細(xì)胞 HMSC-bm
|
公司簡介
|
合肥星肽生物科技有限公司作為專業(yè)的ScienCell中國代理商，專業(yè)經(jīng)營實驗室科研用原代細(xì)胞、原代細(xì)胞專用培養(yǎng)基、原代細(xì)胞無血清培養(yǎng)基、干細(xì)胞、干細(xì)胞培養(yǎng)基、干細(xì)胞無血清培養(yǎng)基的研究和開發(fā)。合肥星肽生物科技有限公司始終致力于為客戶提供可靠的研究材料以及方便快捷的服務(wù)，對購買項目的前期資料提供,中期合同保證,后期貨物跟蹤到 *終售后的確保項目準(zhǔn)確到位，都有相關(guān)專業(yè)人士進(jìn)行維護(hù),確保您在合肥合肥星肽生物科技有限公司公司獲得*上等服務(wù)！
|
|
聯(lián)系方式
|
何經(jīng)理，合肥星肽生物科技有限公司，Tel：0551-63802898 400-8702-898，
E-mail：info@qingbio.com http://m.qkdn.cn QQ:514713116
|
1.) Lee HK, Finniss S, Cazacu S, Bucris E, Ziv-Av A, Xiang C, Bobbitt K, Rempel SA, Hasselbach L, Mikkelsen T, Slavin S, Brodie C. (2013) "Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal."?Oncotarget. 4: 346-61.
2.) Lu L, Song HF, Zhang WG, Liu XQ, Zhu Q, Cheng XL, Yang GJ, Li A, Xiao ZC. (2012) "Potential role of 20S proteasome in maintaining stem cell integrity of human bone marrow stromal cells in prolonged culture expansion."?Biochem Biophys Res Commun. 422: 121-7.
3.) Robin TP, Smith A, McKinsey E, Reaves L, Jedlicka P, Ford HL. (2012) "EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance."?Mol Cancer Res. 10: 1098-108.?
4.) Suh N, Paul S, Lee HJ, Yoon T, Shah N, Son AI, Reddi AH, Medici D, S**** MB. (2012) "Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis."?Osteoarthritis Cartilage. 20: 446-50.
5.) Tan F, Naciri M, Dowling D, Al-Rubeai M. (2012) "In vitro and in vivo bioactivity of CoBlast hydroxyapatite coating and the effect of impaction on its osteoconductivity."Biotechnol Adv. 30: 352-62.
6.) Dissanayaka WL, Zhu X, Zhang C, Jin L. (2011) "Characterization of dental pulp stem cells isolated from canine premolars."?J Endod. 37: 1074-80.
7.) Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, Korkaya H, Heath A, Dutcher J, Kleer CG, Jung Y, Dontu G, Taichman R, Wicha MS. (2011) "Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks."?Cancer Res. 71: 614-24.
8.) Liu Y, Xu X, Ma X, Martin-Rendon E, Watt S, Cui Z. (2010) "Cryopreservation of human bone marrow-derived mesenchymal stem cells with reduced dimethylsulfoxide and well-defined freezing solutions."?Biotechnol Prog. 26: 1635-43.
9.) Chadipiralla K, Yochim JM, Bahuleyan B, Huang CY, Garcia-Godoy F, Murray PE, Stelnicki EJ. (2010) "Osteogenic differentiation of stem cells derived from human periodontal ligaments and pulp of human exfoliated deciduous teeth."?Cell Tissue Res. 340: 323-33.
10.) Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren N, Jia HL, Shi J, Wu JC, Dai C, Dong QZ, Qin LX. (2010) "Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line."?Cancer Sci. 101: 2546-53.
11.) Li M, Jayandharan GR, Li B, Ling C, Ma W, Srivastava A, Zhong L. (2010) "High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy."?Hum Gene Ther. 21: 1527-43.
12.) Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. (2010) "Conversion of vascular endothelial cells into multipotent stem-like cells."?Nat Med. 16: 1400-6.
